Nurses ask CDC to reinstate masking guidelines To view this email as a web page,
click here | | Webinar: New Trends in Virtual Trials Monday, July 26 | 11am ET / 8am PT Last year, clinical trial platform developer Medable raised $91M in private funding, amid the COVID-19 pandemic that touched off huge demand among pharma companies looking to initiate “siteless” or virtual clinical trials. Explore the role of CROs in siteless trials and the opportunities and challenges for CROs to expand their capabilities in this burgeoning area. Register now. |
Qiagen slashes full-year forecast as COVID test sales fall 17% in Q2 Gilead's Veklury shows 'no antiviral effects,' small WHO study says as company stands by COVID med National Nurses United calls on CDC to reinstate masking policies after COVID-19 case spike Ena starts phase 1 trial of COVID-19-preventing nasal spray COVID-19 tracker: J&J, AZ eye tweaks to vaccines, report says; Qiagen cuts financial expectations Featured Story | By Andrea Park In comparison to an original prediction of about 18% to 20% sales growth for the whole year, Qiagen is now expecting to bring in a much more modest 12% bump in year-over-year sales. read more |
| |
|---|
|
| | Webinar: COVID-19 Virus Sequencing for Drug Development Wednesday, July 28 | 10:30am ET / 7:30am PT As new COVID-19 variants continue to emerge, virus sequencing will play critical and ongoing role in drug and vaccine development. This webinar will connect insights from population surveillance to potential solutions for drug developers, outline approaches to COVID-19 virus sequencing and more. Register Now. |
Top Stories By Noah Higgins-Dunn Gilead's Veklury, also known as remdesivir, and hydroxychloroquine didn’t significantly clear the virus from hospitalized COVID-19 patients or affect the degree of respiratory failure and inflammation over standard of care, a small follow-up study to the World Health Organization's Solidarity trial found. read more By Robert King The union National Nurses United is concerned about the rising COVID-19 cases across parts of the U.S. and wants the CDC to reinstate universal masking policies. read more By Nick Paul Taylor Ena Respiratory has begun a phase 1 clinical trial of its nasal spray for the prevention of COVID-19 and other respiratory viral infections. The study is expected to wrap up in the third quarter. read more By Noah Higgins-Dunn,Kevin Dunleavy,Fraiser Kansteiner Johnson & Johnson and AstraZeneca are said to be weighing potential changes to their vaccines to address concerns over blood clots. Qiagen had to cut its 2021 financial expectations as testing demand dries up. And more. read more |
|
